ProfileGDS4718 / 230544_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 51% 48% 52% 52% 43% 45% 51% 45% 53% 46% 49% 48% 50% 46% 51% 49% 44% 44% 50% 50% 45% 52% 53% 47% 47% 49% 42% 43% 45% 47% 45% 45% 53% 50% 44% 50% 50% 48% 45% 49% 49% 44% 52% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.579351
GSM549102patient 115, normal, homogenized [OPG study]5.6014751
GSM549104patient 119, normal, homogenized [OPG study]5.3773848
GSM549108patient 138, normal, homogenized [OPG study]5.6501252
GSM549119patient 077, normal, homogenized [OPG study]5.6264852
GSM549133patient 032, cancer, homogenized [OPG study]5.0693243
GSM549139patient 042, cancer, homogenized [OPG study]5.2052245
GSM549099patient 107, normal, homogenized [OPG study]5.5612251
GSM549109patient 139, normal, homogenized [OPG study]5.2756345
GSM549110patient 046, normal, homogenized [OPG study]5.6565853
GSM549114patient 063, normal, homogenized [OPG study]5.2331346
GSM549122patient 082, normal, homogenized [OPG study]5.4481149
GSM549134patient 033, cancer, homogenized [OPG study]5.3966548
GSM549136patient 036, cancer, homogenized [OPG study]5.4548650
GSM549140patient 044, cancer, homogenized [OPG study]5.2495346
GSM549111patient 047, normal, homogenized [OPG study]5.5578151
GSM549113patient 057, normal, homogenized [OPG study]5.4283149
GSM549132patient 031, cancer, homogenized [OPG study]5.1730144
GSM549137patient 038, cancer, homogenized [OPG study]5.1901644
GSM549142patient 047, cancer, homogenized [OPG study]5.6675850
GSM549100patient 110, normal, homogenized [OPG study]5.5349150
GSM549107patient 135, normal, homogenized [OPG study]5.1931745
GSM549115patient 068, normal, homogenized [OPG study]5.5518652
GSM549116patient 072, normal, homogenized [OPG study]5.6683153
GSM549120patient 078, normal, homogenized [OPG study]5.345247
GSM549131patient 030, cancer, homogenized [OPG study]5.305647
GSM549118patient 074, normal, homogenized [OPG study]5.4476749
GSM549129patient 027, cancer, homogenized [OPG study]5.0935242
GSM549123patient 088, normal, homogenized [OPG study]5.1428143
GSM549124patient 006, cancer, homogenized [OPG study]5.2621945
GSM549126patient 015, cancer, homogenized [OPG study]5.3489847
GSM549128patient 025, cancer, homogenized [OPG study]5.245345
GSM549103patient 117, normal, homogenized [OPG study]5.2987945
GSM549117patient 073, normal, homogenized [OPG study]5.6183553
GSM549138patient 041, cancer, homogenized [OPG study]5.5124850
GSM549141patient 045, cancer, homogenized [OPG study]5.1456144
GSM549130patient 028, cancer, homogenized [OPG study]5.4870950
GSM549101patient 111, normal, homogenized [OPG study]5.5305450
GSM549105patient 128, normal, homogenized [OPG study]5.4023748
GSM549106patient 134, normal, homogenized [OPG study]5.2046545
GSM549112patient 048, normal, homogenized [OPG study]5.4568249
GSM549125patient 011, cancer, homogenized [OPG study]5.492449
GSM549127patient 024, cancer, homogenized [OPG study]5.2108644
GSM549135patient 035, cancer, homogenized [OPG study]5.6128252